HomeCompareRHHBY vs NOBL

RHHBY vs NOBL: Dividend Comparison 2026

RHHBY yields 1.99% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RHHBY wins by $2.1K in total portfolio value
10 years
RHHBY
RHHBY
● Live price
1.99%
Share price
$50.41
Annual div
$1.00
5Y div CAGR
10.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.0K
Annual income
$683.70
Full RHHBY calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — RHHBY vs NOBL

📍 RHHBY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRHHBYNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RHHBY + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RHHBY pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RHHBY
Annual income on $10K today (after 15% tax)
$168.74/yr
After 10yr DRIP, annual income (after tax)
$581.15/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, RHHBY beats the other by $371.88/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RHHBY + NOBL for your $10,000?

RHHBY: 50%NOBL: 50%
100% NOBL50/50100% RHHBY
Portfolio after 10yr
$23.9K
Annual income
$464.94/yr
Blended yield
1.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RHHBY right now

RHHBY
Analyst Ratings
3
Buy
5
Hold
1
Sell
Consensus: Hold
Price Target
$57.00
+13.1% upside vs current
Range: $57.00 — $57.00
Altman Z
4.7
Piotroski
6/9
NOBL
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RHHBY buys
0
NOBL buys
0
No recent congressional trades found for RHHBY or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRHHBYNOBL
Forward yield1.99%2.14%
Annual dividend / share$1.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR10.8%0%
Portfolio after 10y$25.0K$22.8K
Annual income after 10y$683.70$246.19
Total dividends collected$4.1K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: RHHBY vs NOBL ($10,000, DRIP)

YearRHHBY PortfolioRHHBY Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$10,920$219.96$10,914$214.34+$6.00RHHBY
2$11,933$248.72$11,897$218.63+$36.00RHHBY
3$13,050$281.45$12,952$222.72+$98.00RHHBY
4$14,282$318.72$14,086$226.62+$196.00RHHBY
5$15,643$361.21$15,302$230.33+$341.00RHHBY
6$17,148$409.68$16,607$233.85+$541.00RHHBY
7$18,813$465.03$18,007$237.18+$806.00RHHBY
8$20,658$528.31$19,508$240.35+$1.1KRHHBY
9$22,705$600.73$21,116$243.35+$1.6KRHHBY
10$24,978$683.70$22,841$246.19+$2.1KRHHBY

RHHBY vs NOBL: Complete Analysis 2026

RHHBYStock

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Full RHHBY Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this RHHBY vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RHHBY vs SCHDRHHBY vs JEPIRHHBY vs ORHHBY vs KORHHBY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.